SEC Filings

File Date Description Form Downloads
8/11/2015 Form 8K – Q2 2015 Financial Results 8K HTML
8/10/2015 2015 Second Quarter Form 10Q 10Q PDF      XBRL
5/15/2015 Form 8K – Current Report Item 3.01 8K HTML
5/11/2015 2015 First Quarter Form 10Q 10Q PDF      XBRL
4/17/2015 Form 8K – NSP announces a plan to streamline its operations 8K HTML
4/6/2015 Form 8K – Resignation of D. Wynne Roberts 8K HTML
3/27/2015 DEFA 14A Additional Proxy materials 14A PDF
3/27/2015 DEF Schedule 14A 14A PDF
3/13/2015 2014 Form 10K 10K PDF     XBRL
2/26/15 Form 8K – Q4 2014 Financial Results 8K HTML
2/19/15 Form 8K – Amended and Restated Employment Agreement, Gregory L Probert 8K HTML
2/11/15 Form 8K – NSP announces 2015 Annual Meeting of Shareholders to be held May 6, 2015 8K HTML
2/3/2015 Form 8K – NSP announces appointment of Rebecca Lee Steinfort to its Board of Directors 8K HTML
1/15/2015 Form 8K – Stock Incentive Plan and Amendment 1 8K HTML
12/23/2014 Form 8K – NSP announces appointment of Susan M. Armstrong as Chief Operations Officer 8K HTML
11/10/2014 Form 8K – Q3 2014 Financial Results 8K HTML
11/6/2014 2014 Third Quarter Form 10Q 10Q PDF     XBRL
10/20/2014 Form 3 – Paul Noack 3 HTML
10/14/2014 Form 8K – NSP announces appointment of Paul Noack as President of China and New Markets. 8K HTML
9/24/2014 Form 4 – Willem Mesdag 4 HTML
9/23/2014 Form 4 – Albert Dowden 4 HTML
9/23/2014 Form 4 – Mary Beth Springer 4 HTML
9/23/2014 Form 4 – Eugene Hughes 4 HTML
9/22/2014 Form 4 – Steve Bunker 4 HTML
9/22/2014 Form 4 – Robert Mercer 4 HTML
9/22/2014 Form 4 – Gregory Probert 4 HTML
9/22/2014 Form 4 – Wynne Roberts 4 HTML
9/22/2014 Form 4 – Richard Strulson 4 HTML
9/22/2014 Form 4 – Matthew Tripp 4 HTML
9/22/2014 Form 4 – Jeffrey Watkins 4 HTML
9/02/2014 Form 3/A – Shanghai Fosun Pharmaceutical 3/A HTML
9/02/2014 Form 3 – Li Dongjiu 3 HTML
8/29/2014 Form 8K – Operating Agreement among Fosun & NSP Hong Kong Limited 8K HTML
8/29/2014 Form 8K – Amended and restated Bylaws – Standstill agreements 8K HTML
8/19/2014 Form 4 – Gregory Probert 4 HTML
8/7/2014 2014 Second Quarter Form 10Q 10Q PDF     XBRL
8/7/2014 Form 8K – Q2 2014 Earnings Release 8K HTML
8/4/2014 Form 3 – Shanghai Fosun Pharmaceutical 3 HTML
7/2/2014 Form 8K – NSP Announces Strategic Alliance with Fosun Pharma 8K HTML
6/30/2014 Form 11K 11K PDF
5/23/2014 Form 4 – Willem Mesdag 4 HTML
5/09/2014 Form 4 – Albert Dowden 4 HTML
5/09/2014 Form 4 – Eugene Hughes 4 HTML
5/09/2014 Form 4 – Robert Mercer 4 HTML
5/09/2014 Form 4 – Mary Beth Springer 4 HTML
5/09/2014 Form 4 – Jeffrey Watkins 4 HTML
5/8/2014 Form 8K – Q1 2014 Earnings Release 8K HTML
5/8/2014 2014 First Quarter Form 10Q 10Q PDF     XBRL
3/28/2014 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material 14A PDF
3/28/2014 DEF Schedule 14A 14A PDF
3/25/2014 Form 3 - Matthew Tripp 3 HTML
3/19/2014 Form 8K – 2013 Q4 & Year-end earnings release 8K HTML
3/18/2014 Form 4 – Richard Strulson 4 HTML
3/18/2014 Form 4 – Wynne Roberts 4 HTML
3/18/2014 Form 4 – Gregory Probert 4 HTML
3/18/2014 Form 4 – Stephen Bunker 4 HTML
3/17/2014 2013 Form 10K 10K PDF     XBRL
2/18/2014 Form 5 – Eugene Hughes 5 HTML
2/07/2014 Form 8K – NSP announces annual meeting date 8K HTML
12/18/2013 Form 4 – Willem Mesdag 4 HTML
12/17/2013 Form 4 – Eugene Hughes 4 HTML
12/17/2013 Form 4 – Jeffrey Watkins 4 HTML
12/17/2013 Form 4 – Albert R Dowden 4 HTML
12/17/2013 Form 4 – Robert Mercer 4 HTML
11/12/2013 Form 8K – Q3 earnings release 8K HTML
11/08/2013 2013 Third Quarter Form 10Q (Webcast ) 10Q PDF     XBRL
11/04/2013 Form 4 – Richard Strulson 4 HTML
11/04/2013 Form 3 – Richard Strulson 3 HTML
10/28/2013 Form 4 – Wynne Roberts 4 HTML
10/08/2013 Form 8K – Appointment of Richard Strulson as EVP, GC and CCO 8K HTML
10/04/2013 Form 8K – Gregory Probert CEO 8K HTML
9/18/2013 Form 8K – Wayne Moorehead resignation 8K HTML
9/12/2013 Form 4 – Steve Bunker 4 HTML
9/09/2013 Form 8K - Springer appointment to the Board 8K HTML
9/06/2013 Form 4 – Mary Beth Springer 4 HTML
9/06/2013 Form 3 – Mary Beth Springer 3 HTML
8/30/2013 Form 4 – Jamon Jarvis 4 HTML
8/29/2013 Form 4 – Jamon Jarvis 4 HTML
8/27/2013 Form 4 – Jamon Jarvis 4 HTML
8/23/2013 Form 4 – Jamon Jarvis 4 HTML
8/21/2013 Form 4 – Jamon Jarvis 4 HTML
8/19/2013 Form 8-K, Q2 earnings release 8K HTML
8/09/2013 2013 Second Quarter Form 10Q
Listen to Webcast View Webcast Transcript (PDF)
10Q PDF     XBRL
6/28/2013 Form 11-K 11K PDF
6/05/2013 Form S-8 Registration Statement S-8 PDF
5/14/2013 Form 8-K – Q1 earnings release 8K HTML
5/10/2013 Form 4 – Willem Mesdag 4 HTML
5/09/2013 Form 4 – Albert R Dowden 4 HTML
5/09/2013 Form 4 – Robert Mercer 4 HTML
5/09/2013 Form 4 – Gregory Probert 4 HTML
5/09/2013 Form 4 – Eugene L Hughes 4 HTML
5/09/2013 Form 4 – Jeffery D Watkins 4 HTML
5/09/2013 2013 First Quarter Form 10Q 10Q PDF     XBRL
3/29/2013 DEF14A Notice of Annual Meeting & Proxy Statement DEF14A PDF
3/29/2013 DEF14A Additional Materials – Proxy Card DEF14A PDF
3/19/2013 Form 4 – Willem Mesdag 4 HTML
3/11/2013 Form 4 – Willem Mesdag 4 HTML
3/08/2013 PRE14A – Preliminary Proxy Statement PRE14A PDF
3/08/2013 Form 8K - Q4 2012 earnings and dividend 8K PDF
3/07/2013 Form 4 – Steve Bunker 4 HTML
3/07/2013 Form 4 – Michael Dean 4 HTML
3/07/2013 Form 4 – Jamon Jarvis 4 HTML
3/07/2013 Form 4 – Wynne Roberts 4 HTML
3/07/2013 Form 4 – Gregory Probert 4 HTML
3/06/2013 2012 Form 10K 10K PDF     XBRL
2/08/2013 Form 4 – Jeff Watkins 4 HTML
2/08/2013 Form 4 – Albert R Dowden 4 HTML
2/08/2013 Form 4 – Robert Mercer 4 HTML
2/08/2013 Form 4 – Willem Mesdag 4 HTML
2/08/2013 Form 4 – Mark Genender 4 HTML
2/08/2013 Form 4 – Eugene Hughes 4 HTML
2/07/2013 Form 8K - Notice of Annual Meeting 8K HTML

Archive

Find more filings in our SEC Filings Archive.

Request Information

Complete our contact form and select the "Investing" option to request additional information. Thank you.